Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...

Large cohort study finds interstitial lung disease independently increases lung cancer risk across all major subtypes, even ...

Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...

In its second-quarter earnings release, the company said that in July and August 2025 it analyzed interim data from the ...

Pune: Infantry soldier Tariq Aziz (30) is set to return to active duty after undergoing a bilateral lung transplant — the ...

A new study offers encouraging news for older adults with chronic respiratory conditions who may struggle to access traditional gym-based rehabilitation programs. Researchers found that pulmonary ...

Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, today announced its financial results for the second ...

The impact that Bernie Williams’ father had on him was immeasurable. Without the sage advice and caring personality of ...

Public pigeon feeding in Hyderabad, though seen as kindness, can cause severe lung diseases. Experts warn that droppings and ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

Analysts have recently evaluated Liquidia and provided 12-month price targets. The average target is $28.83, accompanied by a ...